Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

MHRA launches new service to accelerate innovative medicine development

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched AdvanceGxP, a new service to provide earlier support for companies developing advanced manufacturing technologies for medicines.

  • AdvanceGxP aims to help innovators address regulatory and quality questions earlier, potentially reducing delays.
  • The service is intended to support patient access to new treatments and strengthen UK manufacturing.
  • Funding from the Office for Life Sciences (OLS) will enable the MHRA to recruit a specialist team for the service.

The Medicines and Healthcare products Regulatory Agency (MHRA) has introduced AdvanceGxP, a new service designed to offer earlier practical support to companies developing advanced manufacturing technologies for medicines. This initiative aims to help promising technologies reach patients more quickly.

AdvanceGxP will initially focus on advanced manufacturing technologies, including personalised treatments made near hospitals and clinics, manufacturing in space, and the use of AI, robotics, and automation. The service is being developed to help innovators address regulatory and quality questions at an earlier stage, which could reduce the risk of avoidable redesigns and delays.

Funding for AdvanceGxP has been secured from the Office for Life Sciences (OLS). The MHRA plans to recruit a new specialist team and develop the service, including how organisations will access it and which technologies will be prioritised. Initial capacity will be limited as the approach is developed and tested.

Why this matters: The service is intended to support patient access to new treatments and strengthen UK manufacturing, aligning with the Government’s Life Sciences Sector Plan and wider Industrial Strategy.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.